During the clinical demo encounter with Xyrem in narcolepsy/cataplexy people at therapeutic doses, two clients noted stress and one particular noted sleeplessness pursuing abrupt discontinuation on the termination from the clinical demo; in the two individuals with stress, the frequency of cataplexy experienced improved markedly concurrently.A nurs